A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD

Thorax

Volumn 70, Issue 1, 2015, Pages 21-32

  Brandsma, Corry Anke ^a   Van Den Berge, Maarten ^a   Postma, Dirkje S ^a   Jonker, Marnix R ^a   Brouwer, Sharon ^a   Paré, Peter D ^b   Sin, Don D ^b   Bossé, Yohan ^c,d   Laviolette, Michel ^c   Karjalainen, Juha ^a   Fehrmann, Rudolf S N ^a   Nickle, David C ^e   Hao, Ke ^e   Spanjer, Anita I R ^a,f   Timens, Wim ^a   Franke, Lude ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; FIBULIN 5; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; FBLN5 PROTEIN, HUMAN; SCLEROPROTEIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOWN REGULATION; ELASTIC FIBER; ELASTIN GENE; FEMALE; FIBULIN 5 GENE; FORCED EXPIRATORY VOLUME; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 2 GENE; LUNG EMPHYSEMA; LUNG FIBROBLAST; MAJOR CLINICAL STUDY; MALE; MICROFIBRILLAR ASSOCIATED PROTEIN 4 GENE; POLYMERASE CHAIN REACTION; SMOKING; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; ELASTICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; BLOTTING, WESTERN; ELASTICITY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, MESSENGER;

EID: 84919734488     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205091     Document Type: Article

References (36)

1. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009;4:435-59.
2. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-75.
3. Spira A, Beane J, Pinto-Plata V, et al. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol 2004;31:601-10.
4. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 2004;101:14895-900.
5. Golpon HA, Coldren CD, Zamora MR, et al. Emphysema lung tissue gene expression profiling. Am J Respir Cell Mol Biol 2004;31:595-600.
6. Wang IM, Stepaniants S, Boie Y, et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008;177:402-11.
7. Bhattacharya S, Srisuma S, Demeo DL, et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol 2009;40:359-67.
8. Hao K, Bosse Y, Nickle DC, et al. Lung eQTLs to help reveal the molecular underpinnings of Asthma. PLoS Genet 2012;8:e1003029.
9. Bosse Y, Sin D, Laviolette M, et al. Hypothesis-driven research on genomic data derived from a large scale lung EQTL mapping study. Webmed Cent Lund 2010;1:WMC00724.
10. Bosse Y, Postma DS, Sin DD, et al. Molecular signature of smoking in human lung tissues. Cancer Res 2012;72:3753-63.
11. Fehrmann RS, Jansen RC, Veldink JH, et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011;7:e1002197.
12. Cvejic A, Haer-Wigman L, Stephens JC, et al. SMIM1 underlies the Vel blood group and influences red blood cell traits. Nat Genet 2013;45:542-5.
13. Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013;45:1238-43.
14. Yanagisawa H, Schluterman MK, Brekken RA. Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J Cell Commun Signal 2009;3:337-47.
15. Yanagisawa H, Davis EC, Starcher BC, et al. Fibulin-5 is an elastinbinding protein essential for elastic fibre development in vivo. Nature 2002;415:168-71.
16. Nakamura T, Lozano PR, Ikeda Y, et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002;415:171-5.
17. Hirai M, Horiguchi M, Ohbayashi T, et al. Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J 2007;26:3283-95.
18. Schlosser A, Thomsen T, Shipley JM, et al. Microfibril-associated protein 4 binds to surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. Scand J Immunol 2006;64:104-16.
19. Callewaert B, Su CT, Van Damme T, et al. Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. Hum Mutat 2013;34:111-21.
20. Kuang PP, Goldstein RH, Liu Y, et al. Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am J Physiol Lung Cell Mol Physiol 2003;285: L1147-52.
21. Deslee G, Woods JC, Moore CM, et al. Elastin expression in very severe human COPD. Eur Respir J 2009;34:324-31.
22. Kuang PP, Joyce-Brady M, Zhang XH, et al. Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity. Am J Physiol Cell Physiol 2006;291:C1412-21.
23. Hirai M, Ohbayashi T, Horiguchi M, et al. Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol 2007;176:1061-71.
24. Budatha M, Silva S, Montoya TI, et al. Dysregulation of protease and protease inhibitors in a mouse model of human pelvic organ prolapse. PLoS ONE 2013;8:e56376.
25. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009;135:173-80.
26. Lee J, Sandford A, Man P, et al. Is the aging process accelarated in chronic obstructive pulmonary disease? Curr Opin Pulm Med 2011;17:90-7.
27. Hiemstra PS, van Wetering S, Stolk J. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Eur Respir J 1998;12:1200-8.
28. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-88.
29. Chen HJ, Lin CM, Lin CS, et al. The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev 2006;20:1933-45.
30. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006;7:15.
31. Konigshoff M, Kneidinger N, Eickelberg O. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009;139:554-63.
32. Quaggin SE, Schwartz L, Cui S, et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999;126:5771-83.
33. Poller W, Barth J, Voss B. Detection of an alteration of the alpha 2-macroglobulin gene in a patient with chronic lung disease and serum alpha 2-macroglobulin deficiency. Hum Genet 1989;83:93-6.
34. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006;290:L209-21.
35. Takayama G, Arima K, Kanaji T, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006;118:98-104.
36. Naik PK, Bozyk PD, Bentley JK, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012;303:L1046-56.